{"database": "lobbying", "table": "lobbying_activities", "rows": [[2772338, "7337541c-fe74-4dbb-94e7-bdc7a5b088c8", "Q1", "THE NICKLES GROUP, LLC", 293335, "OMEROS CORPORATION", 2022, "first_quarter", "GOV", "Monitored H.R. 5376, Build Back Better Act, as it relates to prescription drug prices; H.R.3259, Non-Opioids Prevent Addiction In the Nation Act (NOPAIN Act) and issues involving access for patients to non-opioid alternatives.", "HOUSE OF REPRESENTATIVES", 80000, null, 0, 0, "2022-04-12T15:55:47-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2772338"], "units": {}, "query_ms": 0.4419060132931918, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}